Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifevantage (LFVN) EBIT (2016 - 2025)

Lifevantage (LFVN) has disclosed EBIT for 16 consecutive years, with $487000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT fell 85.79% year-over-year to $487000.0, compared with a TTM value of $9.0 million through Dec 2025, down 17.4%, and an annual FY2025 reading of $12.2 million, up 181.6% over the prior year.
  • EBIT was $487000.0 for Q4 2025 at Lifevantage, down from $2.3 million in the prior quarter.
  • Across five years, EBIT topped out at $6.6 million in Q2 2021 and bottomed at -$1.3 million in Q4 2023.
  • Average EBIT over 5 years is $2.0 million, with a median of $2.0 million recorded in 2021.
  • The sharpest move saw EBIT tumbled 244.13% in 2022, then soared 371.85% in 2024.
  • Year by year, EBIT stood at -$358000.0 in 2021, then crashed by 244.13% to -$1.2 million in 2022, then fell by 2.35% to -$1.3 million in 2023, then skyrocketed by 371.85% to $3.4 million in 2024, then plummeted by 85.79% to $487000.0 in 2025.
  • Business Quant data shows EBIT for LFVN at $487000.0 in Q4 2025, $2.3 million in Q3 2025, and $2.1 million in Q2 2025.